The 2020 International NASH Day went virtual this year, transforming from hundreds of small local events into one large and engaging multi-platform experience that included 80 partner organizations and 25 speakers. This year's goal was to raise awareness and urgency in combatting two parallel epidemics – liver disease and COVID-19.
NASH Day raises awareness of non-alcoholic fatty liver disease (NAFLD), also called non-alcoholic steatohepatitis (NASH) or fatty liver disease, a condition in which fat builds up in the liver NOT due to heavy alcohol use. NAFLD affects 5 to 8 million children and adolescents in the world and is the most common liver disease among pediatric patients in the U.S.
This year's international celebration included a social media campaign and a series of virtual panel discussions that highlighted current challenges and innovative solutions to prevent, identify, treat and improve the list of people living with NASH.
Jennifer Panganiban, MD, director of the Non-alcoholic Fatty Liver Disease Clinic at Children's Hospital of Philadelphia (CHOP) was a speaker on the Virtual Education Panel on Pediatric NASH. CHOP also created an NAFLD awareness video featuring Dr. Panganiban that was shared in person and virtually with CHOP patients and families.
To learn more about the 2020 NASH Day, please see the summary report.
Featured in this article
Specialties & Programs
The 2020 International NASH Day went virtual this year, transforming from hundreds of small local events into one large and engaging multi-platform experience that included 80 partner organizations and 25 speakers. This year's goal was to raise awareness and urgency in combatting two parallel epidemics – liver disease and COVID-19.
NASH Day raises awareness of non-alcoholic fatty liver disease (NAFLD), also called non-alcoholic steatohepatitis (NASH) or fatty liver disease, a condition in which fat builds up in the liver NOT due to heavy alcohol use. NAFLD affects 5 to 8 million children and adolescents in the world and is the most common liver disease among pediatric patients in the U.S.
This year's international celebration included a social media campaign and a series of virtual panel discussions that highlighted current challenges and innovative solutions to prevent, identify, treat and improve the list of people living with NASH.
Jennifer Panganiban, MD, director of the Non-alcoholic Fatty Liver Disease Clinic at Children's Hospital of Philadelphia (CHOP) was a speaker on the Virtual Education Panel on Pediatric NASH. CHOP also created an NAFLD awareness video featuring Dr. Panganiban that was shared in person and virtually with CHOP patients and families.
To learn more about the 2020 NASH Day, please see the summary report.
Contact us
Metabolic Dysfunction-Associated Steatotic Liver Disease Program